TMED2 as a marker of prognosis in breast cancer [Letter]
Megan Catherine Schwarz,1 Silvia Allikmets21Icahn School of Medicine, Mount Sinai Oncological Sciences, New York, NY, USA; 2Faculty of Life Sciences & Medicine, GKT School of Medical Education, King’s College London, London, UKWe thank Lin et al for their interesting study proposin...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/tmed2-as-a-marker-of-prognosis-in-breast-cancer-letter-peer-reviewed-article-CMAR |